905
Views
7
CrossRef citations to date
0
Altmetric
Editorial

Overcoming resistance to mTOR inhibition for enhanced strategies in clinical trials

, MD FACP
Pages 679-685 | Published online: 30 Apr 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Håkon Reikvam, Ina Nepstad & Jerome Tamburini. (2013) Predicting effects of kinase inhibitor in therapy for myeloid malignancies – the challenges in capturing disease heterogeneity. Expert Opinion on Investigational Drugs 22:11, pages 1365-1370.
Read now
Fei Liu, Yong-Qing Wang, Ling Meng, Min Gu & Ruo-Yun Tan. (2013) FK506-binding protein 12 ligands: a patent review. Expert Opinion on Therapeutic Patents 23:11, pages 1435-1449.
Read now

Articles from other publishers (5)

Monica Mita, Siqing Fu, Sarina Anne Piha-Paul, Filip Janku, Alain Mita, Ronald Natale, Wei Guo, Charles Zhao, Razelle Kurzrock & Aung Naing. (2017) Phase I trial of MEK 1/2 inhibitor pimasertib combined with mTOR inhibitor temsirolimus in patients with advanced solid tumors. Investigational New Drugs 35:5, pages 616-626.
Crossref
Aung Naing, Gordon B Mills & Funda Meric-Bernstam. 2016. PI3K-mTOR in Cancer and Cancer Therapy. PI3K-mTOR in Cancer and Cancer Therapy 151 180 .
Manojkumar Bupathi, Ahmed Kaseb, Funda Meric-Bernstam & Aung Naing. (2015) Hepatocellular carcinoma: Where there is unmet need. Molecular Oncology 9:8, pages 1501-1509.
Crossref
Tan Li & Guanyu Wang. (2014) Computer-Aided Targeting of the PI3K/Akt/mTOR Pathway: Toxicity Reduction and Therapeutic Opportunities. International Journal of Molecular Sciences 15:10, pages 18856-18891.
Crossref
Xiaochun Liu, Patricia LoRusso, Monica Mita, Sarina Piha-Paul, David S. Hong, Siqing Fu, Lacey McQuinn, Ekaterine Asatiani, Lawrence A. Doyle, Helen X. Chen, Kenneth R. Hess, Razelle Kurzrock & Aung Naing. (2014) Incidence of Mucositis in Patients Treated With Temsirolimus-Based Regimens and Correlation to Treatment Response. The Oncologist 19:4, pages 426-428.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.